Skip to content
Catalyst

L-arginineFinding

L-arginine decreases preterm birth incidence

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“In comparison to controls, the oral l-arginine groups showed significantly reduced risks of IUGR neonates, pre-term birth and respiratory distress syndrome (n = 7, 3 and 3, respectively) in the total population.”
Quoted verbatim from Effects of prenatal oral L-arginine on birth outcomes: a meta-analysis.
This finding among the 21 findings on its endpoint

L-arginine

Preterm birth incidence

lowers

Who
Pregnant women in pooled randomised trials with high risk of pre-eclampsia, or mild chronic hypertension; three studies, controls placebo or vitamins
Dose studied
oral L-arginine 3 to 6.6 g/day, pooled; one trial gave 6.6 g/day with vitamins against vitamins alone

Moderate evidencePMID 34815460 · 2021

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Scientific reports
What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y4HX034K135WQ6ZR03KTQP